Schizophrenia: The illness that made us human

Medical Hypotheses

Volumn 50, Issue 4, 1998, Pages 269-288

  Horrobin, D F ^a  

^a Scotia Research Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FATTY ACID BINDING PROTEIN; LIPOPROTEIN; PHOSPHOLIPASE;

ADIPOSE TISSUE; AGRICULTURE; BRAIN DEVELOPMENT; BRAIN SIZE; HUMAN; LIPOPROTEIN METABOLISM; METABOLISM; MUSIC; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RELIGION; REVIEW; SCHIZOPHRENIA; SUBCUTANEOUS FAT;

EID: 0031744818     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90000-7     Document Type: Article

References (160)

1. World Health Organization. Schizophrenia: an international follow-up study. New York: Wiley, 1979.
2. Horai S, Hayasaka K, Kondo R, Tsugane K, Takahata N. Recent African origin of modern humans revealed by complete sequences of hominoid mitochondrial DNAs. Proc Natl Acad Sci USA 1995; 92: 532-536.
3. Goldstein D B, Ruiz Linares A, Cavalli Sforza L L, Feldman M W. Genetic absolute dating based on microsatellites and the origin of modern humans. Proc Natl Acad Sci USA 1995; 92: 6723-6727.
4. Vigilant L M, Stoneking M, Harpending H, Hawkes K, Wilson A. African populations and the evolution of human mitochondrial DNA. Science 1991; 253: 1503-1507.
5. Crow T J. Origin of psychosis and "The Descent of Man". Br J Psychiatry 1991; 159 (Suppl. 14): 76-82.
6. Crow T J. Sexual selection, Machiavellian intelligence and the origins of psychosis. Lancet 1993; 342: 594-598.
7. Crow T J. A Darwinian approach to the origins of psychosis. Br J Psychiatry 1995; 167: 12-25.
8. Crow T J. Language and psychosis: Common evolutionary origins. Endeavour 1996; 20: 105-109.
9. Crow T J. Sexual selection as the mechanism of evolution of Machiavellian intelligence: a Darwinian theory of the origins of psychosis. J Psychopharmacol 1996;10: 77-87.
10. Crawford M, Marsh D. The Driving Force: Food, Evolution and the Future. London: Heinemann, 1989.
11. Crawford M A. The role of dietary fats in biology: their place in the evolution of the human brain. Nutr Rev 1992; 50: 3-11.
12. Noble W, Davidson I. Human Evolution: Language and Mind. Cambridge: Cambridge University Press, 1996.
13. Mithen S. The Prehistory of the Mind: A Search for the Origins of Art, Religion and Science. London: Thames and Hudson, 1996.
14. Trinkaus E. The Neanderthals. London: Pimlico, 1994.
15. Krings M, Stone A, Paabo S. Neandertal DNA sequences and the origin of modern humans. Cell 1997; 90: 19-30.
16. Mead J F, Fulco A J. The Unsaturated and Polyunsaturated Fatty Acids in Health and Disease. Springfield, IL: Charles C Thomas, 1976.
17. Horrobin D F. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res 1992; 31: 163-194.
18. British Nutrition Foundation. Unsaturated Fatty Acids: Nutritional and Physiological Significance. London: Chapman and Hall, 1992.
19. Crawford M A, Casperd N M, Sinclair A J. The long chain metabolites of linoleic and linolenic acids in liver and brain in herbivores and carnivores. Comp Biochem Physiol B 1976; 54: 395-401.
20. Crawford M A, Hassam A G, Williams G. Essential fatty acids and fetal brain growth. Lancet 1976; i: 452-453.
21. Carlson S E, Werkman S H, Peeples J M, Cooke R J, Tolley E A. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993; 90: 1073-1077.
22. Koletzko B. Fats for brains. Eur J Clin Nutr 1992; 46: S51-S62.
23. Crawford M A, Costeloe K, Doyle W, Leighfield M J, Lennon E A, Meadows N. Potential diagnostic value of the umbilical artery as a definition of neural fatty acid status of the fetus during its growth: the umbilical artery as a diagnostic tool. Biochem Soc Trans 1990; 18: 761-766.
24. Holdcroft A, Oatridge A, Hajnal J V, Bydder G M. Changes in brain size in normal pregnancy. J Physiol 1997; 498: 54P.
25. Lucas A, Morley R, Cole T J, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992; 339: 261-264.
26. Birch D G, Birch E E, Hoffman D R, Uauy R D. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 1992; 33: 2365-2376.
27. Birch E E, Birch D G, Hoffman D R, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992; 33: 3242-3253.
28. Makrides M, Neumann M, Simmer K, Pater J, Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995; 345: 1463-1468.
29. Willats P, Forsyth J S, DiModugno M K, Varma S, Colvin M. Improved problem solving at 10 months by infants fed a formula supplemented with long-chain polyunsaturated fatty acids. Prostaglandins Leukot EFAs 1997; 57: 188.
30. Davidovitch M, Patterson B, Gartside P. Head circumference measurements in children with autism. J Child Neurol 1996; 11: 389-393.
31. Gardner H. Frames of Mind: The Theory of Multiple Intelligences. New York: Basic Books, 1993.
32. Gardner H. Multiple Intelligences: The Theory in Practice. New York: Basic Books, 1993.
33. Fodor J. The Modularity of Mind. Cambridge, MA: MIT Press, 1985.
34. Cosmides L, Tooley J. Origins of domain specificity: the evolution of functional organisation. In: Hirschfeld L A, Gelman S A, eds. Mapping the Mind: Domain Specificity in Cognition and Culture. Cambridge: Cambridge University Press, 1994: 85-116.
35. Udwin O, Yule W. Expressive language of children with Williams syndrome. Am J Med Genetics 1990; Suppl. 6: 108-114.
36. 2 activity enriched in the nerve growth cone. J Neurochem 1996; 67: 2599-2608.
37. Martin R E, Wickham J Q. Membrane docosahexaenoic acid content influences A-type phospholipase activity in PC12 cell nerve growth cones. Soc Neurosci 1996; 22: 37.
38. Adams J, Collaco Moraes Y, de Belleroche J. Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J Neurochem 1996; 66: 6-13.
39. Yamagata K, Andreasson K I, Kaufmann W E, Barnes C A, Worley P F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-386.
40. Kaufmann W E, Worley P F, Pegg J, Bremer M, Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 1996; 93: 2317-2321.
41. 2-derived arachidonic acid and its metabolites. Brain Res 1996; 721: 39-48.
42. Hess D T, Patterson S I, Smith D S, Skene J H P. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 1993; 366: 562-565.
43. Nelson R J, Demas G E, Huang P L et al. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995; 378: 383-386.
44. Omawari N, Mahmood S, Dewhurst M, Stevens E J, Tomlinson D R. Deficient nitric oxide is responsible for reduced nerve blood flow in diabetic rats: prevention by essential fatty acids. Br J Pharmacol 1995; 116: 63.
45. Huttenlocher P R, deCourten C, Garey L J, van der Loos H. Synaptogenesis in human visual cortex: evidence for synapse elimination during normal development. Neurosci Lett 1982; 33: 247-252.
46. Purves D, Lichtman J W. Elimination of synapses in the developing nervous system. Science 1980; 210: 153-157.
47. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982-1983; 17: 319-334.
48. Inoue A, Sanes J R. Lamina-specific connectivity in the brain: regulation by N-cadherin, neurotrophins, and glycoconjugates. Science 1997; 276: 1428-1431.
49. Jiang W G, Hiscox S, Hallett M B, Horrobin D F, Mansel R E, Puntis M C A. Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid (GLA). Cancer Res 1995; 55: 5043-5048.
50. Mead J F, Alfin-Slater R B, Howton D R, Popjak G. Lipids: Chemistry, Biochemistry, and Nutrition. New York: Plenum, 1986.
51. Vance D E, Vance J, eds. Biochemistry of Lipids, Lipoproteins and Membranes. Amsterdam: Elsevier, 1991.
52. Farstad M. Metabolism of fatty acids of human blood platelets: possible relation to disease. Scand J Clin Lab Invest 1993; 53: 39-45.
53. Eckel R H, Robbins R J. Lipoprotein lipase is produced, regulated, and functional in rat brain. Proc Natl Acad Sci USA 1984; 81: 7604-7607.
54. Tavangar K, Murata Y, Patel S et al. Developmental regulation of lipoprotein lipase in rats. Am J Physiol 1992; 262: E330-E337.
55. Shirai K, Saito Y, Yoshida S, Matsuoka N. Existence of lipoprotein lipase in rat brain microvessels. Tohoku J Exp Med 1986; 149: 449-450.
56. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707.
57. Enerback S, Gimble J M. Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1993; 1169: 107-125.
58. Myers-Payne S C, Hubell T, Pu L et al. Isolation and characterization of two fatty acid binding proteins from mouse brain. J Neurochem 1996; 66: 1648-1656.
59. Gossett R E, Frolov A A, Roths J B, Behnke W D, Kier A B, Schroeder F. Acyl-CoA binding proteins: multiplicity and function. Lipids 1996; 31: 895-918.
60. Maudsley H. Heredity, Variation and Genius. London: Bale and Daniellson, 1908.
61. Shorter E. A History of Psychiatry: from the Era of the Asylum to the Age of Prozac. New York: Wiley, 1997.
62. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Association, 1994.
63. Kirk S, Kutchins H. The Selling of DSM: The Rhetoric of Science in Psychiatry. New York: Aldine and Gruyter, 1992.
64. Crow T J. The two syndrome concept: origins and current status. Schizophr Bull 1985; 11: 471-486.
65. Crow T J. Psychosis as a continuum and the virogene concept. Br Med Bull 1987; 43: 754-767.
66. Kendell R E. Diagnosis and classification of functional psychoses. Br Med Bull 1987; 43: 499-513.
67. Kendell R E. Clinical validity. Psychol Med 1989; 19: 45-55.
68. Kasanin J. The acute schizoaffective psychoses. Am J Psychiatry 1933; 90: 97-126.
69. Claridge G. Origins of Mental Illness. Oxford: Blackwell, 1985.
70. Claridge G. Single indicator of risk for schizophrenia: probable fact or likely myth. Schizo Bull 1994; 20: 151-168.
71. Claridge G. Schizotypy: Implications for Illness and Health. Oxford: Oxford University Press, 1997.
72. Raine A, Lencz T, Mednick S A. Schizotypal Personality. Cambridge: Cambridge University Press, 1995.
73. Richardson A J. Dyslexia, Handedness and syndromes of psychosis-proneness. Int J Psychophysiol 1994;18: 251-263.
74. Rosenthal D, Kety S. The Transmission of Schizophrenia. Oxford: Pergamon, 1968.
75. Kety S S, Wender P H, Jacobsen B et al. Mental illness in the biological and adoptive relatives of schizophrenic adoptees, II: replication of the Copenhagen study in the rest of Denmark. Arch Gen Psychiatry 1994; 51: 442-455.
76. Heston L L. Psychiatric disorders in foster-home-reared children of schizophrenic mothers. Br J Psychiatr 1966; 122: 819-825.
77. Heston L L. The genetics of schizophrenic and schizoid diseases. Science 1970; 167: 249-256.
78. Karlsson J L. The Biologic Basis of Schizophrenia. Springfield, IL: Thomas, 1966.
79. Karlsson JL. Inheritance of schizophrenia. Acta Psychiatr Scand Suppl 1974; 274: 1-116.
80. Kay D W K, Roth M, Atkinson M W, Stephens D A, Garside R F. Genetic hypotheses and environmental factors in the light of psychiatric morbidity in the families of schizophrenics. Br J Psychiatry 1975; 127: 109-118
81. Varma S L, Zain A M, Singh S. Psychiatric morbidity in first-degree relatives. Am J Med Genet 1997; 74: 7-11.
82. Stephens D A, Atkinson M W, Kay D W K, Roth M, Garside RF. Psychiatric morbidity in parents and sibs of schizophrenics and non-schizophrenics. Br J Psychiatry 1975; 127: 97-108.
83. Silverton L. Crime and the schizophrenia spectrum. Acta Psychiatr Scand 1988; 78: 72-81.
84. Alanen O. The mothers of schizophrenic patients. Acta Psychiatr Neurol Scand 1958; 33(Suppl. 124): 5-361.
85. Christensen O, Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand 1988; 78: 587-591.
86. Foley R A. Causes and consequences in human evolution. J R Anthropol Soc 1995;1: 67-86.
87. Aiello L C, Dunbar R I M. Neocortex size, group size, and the evolution of language. Curr Anthropol 1993; 34: 184-193.
88. Rose L, Marshall F. Meat eating, hominid sociality, and home bases revisited. Curr Anthropol 1996; 37: 307-338.
89. Horrobin D F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Res; in press.
90. 2 and the hypofrontality hypothesis of schizophrenia. Prostaglandins Leukot EFAs 1996; 55: 109-113.
91. 2 activity in schizophrenia: a replication study. Biol Psychiatry 1990; 28: 495-501.
92. Horrobin D F. Schizophrenia as a prostaglandin deficiency disease. Lancet 1977; i: 936-937.
93. Horrobin D F. Schizophrenia: reconciliation of the dopamine, prostaglandin, and opioid concepts and the role of the pineal. Lancet 1979; i: 529-531.
94. Horrobin D F. The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism. Prostaglandins Leukot EFAs 1992; 46: 71-77.
95. Horrobin D F. A possible relationship between dyslexia and schizophrenia, two disorders in which membrane phospholipid (PL) metabolism is disturbed. Schizophr Res 1996; 18: 156.
96. Horrobin D F. Overview of the phospholipid hypothesis of schizophrenia. Prostaglandins Leukot EFAs 1997; in press.
97. Horrobin D F, Ally A I, Karmali R A, Karmazyn M, Manku M S, Morgan R O. Prostaglandins and schizophrenia: further discussion of the evidence. Psychol Med 1978; 8: 43-48.
98. Horrobin D F, Glen A I, Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195-207.
99. Horrobin D F, Glen A I M, Hudson C J. Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia. Med Hypotheses 1995; 45: 605-613.
100. Glen A I M, Cooper S J, Rybakowski J, Vaddadi K, Brayshaw N, Horrobin D F. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot EFAs 1996; 15: 9-15.
101. Glen A I M, Glen E M, Horrobin D F et al. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res 1994; 12: 53-61.
102. Ward P, Sutherland J, Glen E, Glen I. Niacin skin flush in schizophrenia. Schizophr Res 1997; in press.
103. Mahadik S P, Evans D R. Essential fatty acids in the treatment of schizophrenia. Drugs of Today 1997; 33: 5-17.
104. Mahadik S P, Gowda S. Antioxidants in the treatment of schizophrenia. Drugs Today 1996; 32: 553-565.
105. Peet M, Laugharne J D, Horrobin D F, Reynolds G P. Arachidonic acid: a common link in the biology of schizophrenia? Arch Gen Psychiatry 1994; 51: 665-666.
106. Peet M, Laugharne J D E, Ahluwalia N, Mellor J. Fatty acid supplementation in schizophrenic patients. Schizophr Res 1997; 24: 209.
107. Peet M, Laugharne J D E, Mellor J, Ramchand C N. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot EFAs 1996; 55: 71-75.
108. Peet M, Poole J, Laugharne J. Infant feeding and the development of schizophrenia. Schizophr Res 1997; 24: 255.
109. Pettegrew J W, Keshavan M S, Minchew N J. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophr Bull 1993; 19: 35-53.
110. 2 associated with schizophrenia. Schizophr Res 1996; 21: 111-116.
111. Hudson C J, Lin A, Cogan S, Cashman F, Warsh J J. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry 1997; 41: 507-513.
112. Ross B M, Hudson C, Erlich J, Warsh J J, Kish S J. Increased phospholipid breakdown in schizophrenia - evidence for the involvement of a calcium-independent phospholipase A2. Arch Gen Psychiatry 1997; 54: 487-494.
113. Horrobin D F. Niacin flushing, prostaglandin E and evening primrose oil: a possible objective test for monitoring therapy in schizophrenia. J Orthomolecular Psychiatry 1980; 9: 33-34.
114. Martin R E, Wickham J Q. Membrane docosahexaenoic acid content influences A-type phospholipase activity in PC12 cell nerve growth cones. Society for Neuroscience 1996; 22: 37.
115. Laposata M, Reich E L, Majerus P W. Arachidonoyl-CoA synthetase: separation from non-specific acyl-CoA synthetase and distribution in various cells and tissues. J Biol Chem 1985; 260: 11016-11020.
116. Stordy B J. Benefit of docosahexaenoic acid supplements to dark adaptation in dyslexies. Lancet 1995; 346: 385.
117. Stordy B J. Dark adaption, docosahexaenoic acid and dyslexia. International Conference on Highly Unsaturated Fatty Acids in Nutrition and Disease Prevention. Barcelona, Spain, 4-6 November 1996.
118. Richardson A J, Cox I J, Sargentoni J, Puri B K. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorous-31 magnetic resonance spectroscopy. NMR Biomed 1997; in press.
119. Horrobin D F, Manku M S. Possible role of prostaglandin E1 in the affective disorders and in alcoholism. Br Med J 1980; 280: 1363-1366.
120. Horrobin D F, Mtabaji J P, Manku M S, Karmazyn M. Lithium as a regulator of hormone-stimulated prostaglandin synthesis: relevance to manic-depressive illness. In: Johnson F N, Johnson S, eds. Lithium in Medical Practice. Baltimore: University Park Press, 1978: 243-246.
121. Chang M C J, Grange E, Rabin O, Bell JM, Allen D D, Rapoport S I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci Lett 1996; 220: 171-174.
122. Glen A I M, Glen E, Ward P. Topical niacin flushing in manic-depressive individuals. In preparation 1997.
123. Yao J K, van Kammen D P, Gurklis J A. Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia. Psychiatry Res 1996; 60: 11-21.
124. Horrobin D F. Essential fatty acids, prostaglandins, and alcoholism: an overview. Alcohol Clin Exp Res 1987; 11: 2-9.
125. Glen I, Skinner F, Glen E, MacDonell L. The role of essential fatty acids in alcohol dependence and tissue damage. Alcohol Clin Exp Res 1987; 11: 37-41.
126. Glen E M T, MacDonell L E F, Skinner F K, Ward P E, Brayshaw N, Glen A I M. Significant effects of Li-GLA supplementation in severe alcohol dependence. Prostaglandins Leukot EFAs 1997; 57: 197.
127. Goodwin F K, Jamison K R. Manic-Depressive Illness. Oxford: Oxford University Press, 1990.
128. Ludwig A M. The Price of Greatness. New York: Guilford Press, 1995.
129. Hershman D J, Lieb J. The Key to Genius. New York: Prometheus Books, 1988.
130. Jamison K R. An Unquiet Mind: A Memoir of Moods and Madness. London: Picador, 1995.
131. Milligan S, Clare A. Depression and How to Survive It. London: Ebury Press, 1993.
132. Davis R D. The Gift of Dyslexia. Burlingame, CA: Ability Workshop Press, 1995.
133. Takahashi R, Ito H, Horrobin D F. Fatty acid composition of serum phospholipids in an elderly institutionalized Japanese population. J Nutr Sci Vitaminol Tokyo 1991; 37: 401-409.
134. Horrobin D F. Loss of delta-6-desaturase (D6D) activity as a key factor in aging. Age 1981; 4: 139.
135. Bourre J M, Dinh L, Boithias C, Dumont O, Piciotti M N, Cunnane S. Possible role of the choroid plexus in the supply of brain tissue with polyunsaturated fatty acids. Neurosci Lett 1997; 224: 1-4.
136. Delton-Vanddenbroucke I, Grammas P, Anderson R E. Polyunsaturated fatty acid metabolism in retinal and cerebral microvascular endothelial cells. J Lipid Res 1997; 38: 147-159.
137. Gavin L A, Cavalieri R R, Moeller M, McMahon F A, Castle J N, Gulli R. Brain lipoprotein lipase is responsive to nutritional and hormonal modulation. Metabolism 1987; 36: 919-924.
138. Hang J, Rillema J A. Prolactin's effects on lipoprotein lipase (LPL) activity and on LPL mRNA levels in cultured mouse mammary gland explants. Proc Soc Exp Biol Med 1997; 214: 161-166.
139. Wallberg-Jonsson S, Dahlen G, Johnson O, Olivecrona G, Rantapaa-Dahlqvist S. Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis. J Intern Med 1996; 240: 373-380.
140. Morgan E. The Aquatic Ape Hypothesis. London: Souvenir Press, 1997.
141. Morgan E. The Descent of the Child. London: Souvenir Press, 1994.
142. Murthy V, Julien P, Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 1996; 70: 101-135.
143. Kendler K S, Maclean C J, O'Neill A. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high-density schizophrenia families. Am J Psych 1996; 153: 134-154.
144. Jemaa R, Tuzet S, Betoulle D, Apfelbaum M, Fumeron F. Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int J Obes 1997; 21: 280-283.
145. Oloyede O B, Folyan A T, Odutuga A A. Effects of low-iron status and deficiency of essential fatty acids on some biochemical constituents of rat brain. Biochem Int 1992; 27: 913-922.
146. Broadhurst C L, Cunnane S C, Crawford M A. Rift valley lake fish and shellfish provided brain specific nutrition for early Homo. Br J Nutr 1997; in press.
147. Verhaegen M. The aquatic ape theory: evidence and a possible scenario. Med Hypotheses 1985;16: 17-32.
148. Roede M, Wind J, Patrick J, Reynolds V, eds. The Aquatic Ape: Fact or Fiction? London: Souvenir Press, 1991.
149. Rousselot P, Heintz N, Nottebohm F. Expression of brain lipid binding protein in the brain of the adult canary and its implications for adult neurogenesis. J Comp Neurol 1997; 385: 415-426.
150. O'Donovan D K. Hypothyroid nails and evolution. Lancet 1996; 347: 1261-1262.
151. O'Donovan D K. Hypothyroid nails and evolution. Lancet 1996; 348: 750-751.
152. Ginobili de Martinez M S, Rodriguez de Turco E B, Barrantes F J. Endogenous asymmetry of rat brain lipids and dominance of the right cerebral hemisphere in free fatty acid response to electroconvulsive shock. Brain Res 1985; 339: 315-321.
153. 2+ and phospholipid-dependent protein kinase activity in rat cerebral hemispheres. Brain Res 1988; 440: 386-390.
154. Pediconi M F, Rodriguez de Turco E B. Free fatty acid content and release kinetics as manifestations of cerebral lateralization in mouse brain. J Neurochem 1984; 43: 1-7.
155. Mellor J E, Laugharne J D E, Peet M. Schizophrenic symptoms and dietary intake of n-3 fatty acids. Schizophr Res 1995; 18: 85-86.
156. Mellor J E, Laugharne J D E, Peet M. Omega-3 fatty acid supplementation in schizophrenia patients. Hum Psychopharm 1996; 11: 39-46.
157. Peet M, Laugharne J D E, Ahluwalia N, Mellor J. Fatty acid supplementation in schizophrenic patients. Schizophr Res 1997; 24: 209.
158. Yoshida S, Yasuda A, Kawazato H et al. Synaptic vesicle ultrastructural changes in the rat hippocampus induced by a combination of alpha-linolenate deficiency and a learning task. J Neurochem 1997; 68: 1261-1268.
159. Yoshida S, Miyazaki M, Takeshita M. Functional changes of rat brain microsomal membrane surface after learning task depending on dietary fatty acids. J Neurochem 1997; 68: 1269-1277.
160. Chadwick P K. Schizophrenia: The Positive Perspective. London: Routledge, 1997.